Shital Kamble

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong et al. · Journal of Clinical Oncology · 2018 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +16

Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin

Allison Keshishian, Shital Kamble, Xianying Pan et al. · Thrombosis and Haemostasis · 2016 · 261 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Incremental Direct Expenditure of Treating Asthma in the United States

Shital Kamble, Murtuza Bharmal · Journal of Asthma · 2009 · 179 citations

Pharmacy, Pharmacoeconomics, Health Economics +16

Depression, quality of life, and medical resource utilization in sickle cell disease

Soheir Adam, Charlene Flahiff, Shital Kamble et al. · Blood Advances · 2017 · 120 citations · Full text

Social Sciences, Health Sciences, Outcomes Research +11

Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the United States

Gregory Y.H. Lip, Xianying Pan, Shital Kamble et al. · International Journal of Clinical Practice · 2016 · 105 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15